Pregnancy and myeloproliferative neoplasms study
Part of Blood & lymphatic clinical trials.
This study looks at how pregnancy affects people with myeloproliferative neoplasms (MPNs), which are blood disorders that cause the body to make too many blood cells. It aims to learn more about outcomes for mothers and babies, and how to manage these conditions during pregnancy. You can join if you are pregnant and have an MPN.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of a myeloproliferative neoplasm (MPN), such as essential thrombocythemia, polycythemia vera, or myelofibrosis. Even if you haven't had a bone marrow biopsy, you can join if you have the gene mutation and meet other criteria.
- You must be pregnant, confirmed by a pregnancy test (urine or blood) or an ultrasound, and you can join at any stage of pregnancy.
- You must be able to take part in the study procedures and understand the study.
- You must give your consent to participate.
- You cannot join if you have other types of blood cancer (like chronic myeloid leukemia or myelodysplastic syndrome), blasts at 10% or higher, uncontrolled autoimmune disease or infections, or another cancer requiring treatment.
- You must not need a legally authorized representative to make decisions for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for specific immune system clues in patients with myeloproliferative neoplasms—rare blood disorders where your bone marrow produces too many blood cells. By identifying these markers, researchers hope to better understand and eventually treat these conditions.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This study looks at heart and blood vessel problems in people with certain blood cancers called myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. It aims to understand how these conditions affect the heart and blood vessels, which may lead to better care.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
This is a research registry for people who have certain blood cancers called myeloproliferative neoplasms (MPNs). It helps researchers learn about the disease over time and may help future studies find and compare patients.
This study explores whether certain inherited gene changes make people more likely to develop myeloproliferative neoplasms (MPNs). It is looking at patients who were diagnosed at a young age or have a family history of blood cancers, to better understand the genetic causes of these conditions.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.